Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in BIOA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | a16z Capital Management, L.L.C. | 3.2M | $79.2M | 0.0% | 8.588% | 0.56% |
| 2 | BlackRock, Inc. | 2.8M | $69.8M | +25.6% | 7.567% | 0.00% |
| 3 | Cormorant Asset Management, LP | 2.4M | $58.6M | -17.3% | 6.350% | 3.00% |
| 4 | Sofinnova Investments, Inc. | 2.3M | $56.2M | 0.0% | 6.093% | 2.91% |
| 5 | Jupiter Topco LLC | 2.1M | $52.6M | — | 5.696% | 0.02% |
| 6 | Octagon Capital Advisors LP | 1.7M | $42.8M | 0.0% | 4.643% | 3.85% |
| 7 | RA CAPITAL MANAGEMENT, L.P. | 1.7M | $41.0M | +1.3% | 4.440% | 0.36% |
| 8 | MPM BioImpact LLC | 1.7M | $40.9M | — | 4.429% | 2.49% |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $37.8M | +14.0% | 4.102% | 0.00% |
| 10 | Polar Capital Holdings Plc | 1.1M | $26.3M | -5.3% | 2.848% | 0.06% |
| 11 | BRAIDWELL LP | 1.0M | $25.3M | -14.0% | 2.744% | 0.94% |
| 12 | STATE STREET CORP | 1.0M | $25.0M | +20.1% | 2.713% | 0.00% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $24.6M | +34.0% | 2.667% | 0.00% |
| 14 | Sands Capital Alternatives, LLC | 786K | $19.3M | 0.0% | 2.089% | 3.14% |
| 15 | ORBIMED ADVISORS LLC | 752K | $18.4M | +5.7% | 1.998% | 0.34% |
| 16 | D. E. Shaw & Co., Inc. | 743K | $18.2M | +6.2% | 1.973% | 0.01% |
| 17 | BALYASNY ASSET MANAGEMENT L.P. | 703K | $17.2M | -47.1% | 1.867% | 0.02% |
| 18 | Pivotal bioVenture Partners Investment Advisor LLC | 653K | $16.0M | 0.0% | 1.735% | 5.20% |
| 19 | Cosmic Management, LLC | 502K | $12.3M | 0.0% | 1.333% | 3.22% |
| 20 | STEMPOINT CAPITAL LP | 464K | $11.4M | +37.1% | 1.233% | 1.96% |
| 21 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 413K | $10.1M | +199.7% | 1.097% | 0.00% |
| 22 | VANGUARD PORTFOLIO MANAGEMENT LLC | 410K | $10.1M | +42.9% | 1.089% | 0.00% |
| 23 | Squadron Capital Management LLC | 405K | $9.9M | — | 1.076% | 3.08% |
| 24 | DIMENSIONAL FUND ADVISORS LP | 394K | $9.7M | +83.7% | 1.047% | 0.00% |
| 25 | JACOBS LEVY EQUITY MANAGEMENT, INC | 377K | $9.2M | -10.2% | 1.002% | 0.03% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in BIOA — a direct measure of their conviction.
Filings activity in BIOA during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 150 | +2.7% | 102.86% | +8.53 pp | $943M | +59% |
| Q1 2026 | 146 | +29% | 94.33% | +17.68 pp | $594M | +94% |
| Q4 2025 | 113 | +23% | 76.65% | +4.00 pp | $306M | +144% |
| Q3 2025 | 92 | +11% | 72.65% | +1.82 pp | $126M | +46% |
| Q2 2025 | 83 | +24% | 70.83% | +1.77 pp | $86M | +13% |
| Q1 2025 | 67 | +4.7% | 69.06% | +2.49 pp | $76M | 33% |
| Q4 2024 | 64 | +10% | 66.57% | 6.92 pp | $113M | 73% |
| Q3 2024 | 58 | — | 73.49% | — | $420M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying BIOA stock.
Based on Q2 2026 13F filings, institutional ownership of BioAge Labs Inc. stands at 102.9%, held across 150 reporting institutions.
a16z Capital Management, L.L.C. is the largest reported institutional holder of BIOA, with approximately 3,233,170 shares worth $0.08B as of Q2 2026.
Yes — 1 widely-followed marquee investor appear among the top 25 institutional holders of BIOA, including SUSQUEHANNA INTERNATIONAL GROUP, LLP.
Our composite Smart Money Score for BIOA is 61 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
25 institutions opened new positions in BIOA during Q2 2026, while 19 fully exited. 109 added to existing positions and 15 trimmed.
BIOA institutional ownership rose by 8.53 percentage points quarter-over-quarter, with a net change of +4 holders.
The top 10 institutions account for 53.6% of all reported 13F value in BIOA, and the top 25 account for 78.7%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
BioAge Labs Inc. (BIOA) Institutional Ownership